Sponsor:
Kyverna Therapeutics
Code:
NCT05938725
Conditions
Lupus Nephritis
Lupus Nephritis - World Health Organization (WHO) Class III
Lupus Nephritis - WHO Class IV
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
KYV-101 anti-CD19 CAR-T cell therapy
Standard lymphodepletion regimen
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations